Evidence map›Paper›PMID 26159176›Full record

ArticleDiabetes2015

A Missense Mutation in PPP1R15B Causes a Syndrome Including Diabetes, Short Stature, and Microcephaly.

Baroj Abdulkarim, Marc Nicolino, Mariana Igoillo-Esteve, Mathilde Daures, Sophie Romero, Anne Philippi, Valérie Senée, Miguel Lopes, Daniel A Cunha, Heather P Harding and 7 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Diabetes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Distinct cell type-specific mechanisms underlie cognitive dysfunction during persistent integrated stress response activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Function and regulation of the mitochondrial stress response.Nature structural & molecular biology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Neonatal and Syndromic Forms of Diabetes.Current diabetes reports · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The ISR downstream target ATF4 represses long-term memory in a cell type-specific manner.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 3 countries.

Baroj AbdulkarimULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
Marc NicolinoHôpital Femme-Mère-Enfant, Division of Pediatric Endocrinology, Hospices Civils de Lyon, Lyon 1 University, Lyon, France INSERM U870, Lyon, France INSERM CIC201, Lyon, France marc.nicolino@chu-lyon.fr mcnop@ulb.ac.be cecile.julier@inserm.fr.
Mariana Igoillo-EsteveULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
Mathilde DauresINSERM UMR-S958, Faculté de Médecine Paris Diderot, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Sophie RomeroINSERM UMR-S958, Faculté de Médecine Paris Diderot, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Anne PhilippiINSERM UMR-S958, Faculté de Médecine Paris Diderot, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Valérie SenéeINSERM UMR-S958, Faculté de Médecine Paris Diderot, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Miguel LopesULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
Daniel A CunhaULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
Heather P HardingCambridge Institute for Medical Research, University of Cambridge, and National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, U.K.
Céline DerboisInstitut de Génomique, Centre National de Génotypage, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France.
Nathalie BendelacHôpital Femme-Mère-Enfant, Division of Pediatric Endocrinology, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.
Andrew T HattersleyUniversity of Exeter Medical School, University of Exeter, Exeter, U.K.
Décio L EizirikULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
David RonCambridge Institute for Medical Research, University of Cambridge, and National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, U.K.
Miriam CnopULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium Division of Endocrinology, Erasmus Hospital, Brussels, Belgium marc.nicolino@chu-lyon.fr mcnop@ulb.ac.be cecile.julier@inserm.fr.
Cécile JulierINSERM UMR-S958, Faculté de Médecine Paris Diderot, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France marc.nicolino@chu-lyon.fr mcnop@ulb.ac.be cecile.julier@inserm.fr.
Université Libre de Bruxelles · BEUniversité Paris Cité · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRDélégation Paris 7 · FRErasmus Hospital · BEHôpital Femme Mère Enfant · FRHospices Civils de Lyon · FRInserm · FRSorbonne Paris Cité · FRUniversity of Exeter · GB

Funding

Wellcome Trust 084812Wellcome Trust 084812/Z/08/ZWellcome Trust 098395Wellcome Trust 100140
6 · The paper itself

Abstract

Dysregulated endoplasmic reticulum stress and phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) are associated with pancreatic β-cell failure and diabetes. Here, we report the first homozygous mutation in the PPP1R15B gene (also known as constitutive repressor of eIF2α phosphorylation [CReP]) encoding the regulatory subunit of an eIF2α-specific phosphatase in two siblings affected by a novel syndrome of diabetes of youth with short stature, intellectual disability, and microcephaly. The R658C mutation in PPP1R15B affects a conserved amino acid within the domain important for protein phosphatase 1 (PP1) binding. The R658C mutation decreases PP1 binding and eIF2α dephosphorylation and results in β-cell apoptosis. Our findings support the concept that dysregulated eIF2α phosphorylation, whether decreased by mutation of the kinase (EIF2AK3) in Wolcott-Rallison syndrome or increased by mutation of the phosphatase (PPP1R15B), is deleterious to β-cells and other secretory tissues, resulting in diabetes associated with multisystem abnormalities.

Indexed as

Mutation, MissenseAdolescentAdultDiabetes MellitusFemaleGrowth DisordersHumansMaleMicrocephalyProtein Phosphatase 1SyndromeProtein Phosphatase 1

Identifiers

PMID26159176
PMCPMC4713904
OpenAlexW1924601622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.